MOSTI, LUISA
 Distribuzione geografica
Continente #
EU - Europa 8.778
AS - Asia 981
NA - Nord America 660
Continente sconosciuto - Info sul continente non disponibili 97
SA - Sud America 92
AF - Africa 12
OC - Oceania 2
Totale 10.622
Nazione #
IT - Italia 8.624
US - Stati Uniti d'America 623
SG - Singapore 442
CN - Cina 242
VN - Vietnam 158
FR - Francia 66
BR - Brasile 59
HK - Hong Kong 41
BD - Bangladesh 35
AR - Argentina 21
DE - Germania 19
FI - Finlandia 14
GB - Regno Unito 14
CA - Canada 12
IN - India 12
JP - Giappone 12
CH - Svizzera 11
ID - Indonesia 6
MX - Messico 6
RU - Federazione Russa 6
ZA - Sudafrica 6
EC - Ecuador 5
CO - Colombia 4
ES - Italia 4
IQ - Iraq 4
KH - Cambogia 4
PH - Filippine 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
JM - Giamaica 3
JO - Giordania 3
NL - Olanda 3
TR - Turchia 3
AU - Australia 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
IE - Irlanda 2
KR - Corea 2
PR - Porto Rico 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UA - Ucraina 2
UZ - Uzbekistan 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CL - Cile 1
DZ - Algeria 1
EG - Egitto 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KW - Kuwait 1
NG - Nigeria 1
NP - Nepal 1
PK - Pakistan 1
PL - Polonia 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SV - El Salvador 1
TN - Tunisia 1
VE - Venezuela 1
Totale 10.525
Città #
Genova 5.535
Genoa 1.886
Rapallo 602
Vado Ligure 541
Singapore 249
San Jose 203
Ashburn 70
Lauterbourg 63
Ho Chi Minh City 45
Hong Kong 40
Hanoi 38
New York 37
Beijing 36
Santa Clara 24
Frankfurt am Main 16
Los Angeles 15
Helsinki 13
Tokyo 11
Milan 10
Zurich 10
Atlanta 8
Dallas 8
Bordighera 7
Chicago 7
Da Nang 7
Haiphong 7
Naples 7
Rome 7
Tianjin 7
Mexico City 6
Cardiff 5
Houston 5
São Paulo 5
Buenos Aires 4
Johannesburg 4
Montreal 4
Mumbai 4
Newark 4
Phnom Penh 4
Alexandria 3
Bengaluru 3
Buffalo 3
Can Tho 3
Curitiba 3
Denver 3
Des Moines 3
Edinburg 3
London 3
Memphis 3
Miami 3
Nha Trang 3
Orem 3
Philadelphia 3
Queens 3
San José 3
Wuhan 3
Amman 2
Amsterdam 2
Asheville 2
Baghdad 2
Belo Horizonte 2
Billings 2
Birmingham 2
Biên Hòa 2
Bossier City 2
Boston 2
Brooklyn 2
City of London 2
Córdoba 2
Davao City 2
Dublin 2
Franklin 2
Jakarta 2
Kapolei 2
Kingston 2
Lake Providence 2
Lincoln 2
Mesa 2
Newton 2
Palermo 2
Phillipsburg 2
Piscataway 2
Richmond 2
Rio de Janeiro 2
Saint Paul 2
San Francisco 2
San Mateo 2
San Pedro Sula 2
San Tan Valley 2
Santo Domingo 2
Silver Spring 2
Sioux Falls 2
Southlake 2
Tashkent 2
Thái Nguyên 2
Van Alstyne 2
Van Nuys 2
Zagreb 2
Zhengzhou 2
Agua de Oro 1
Totale 9.692
Nome #
1-Phenyl-1H-Indazole derivatives with analgesic and anti-inflammatory activities. 214
An efficient synthesis of functionalized 2-pyridones by direct route or via amide/enolate ammonium salt intermediates 214
Chemometric study and validation strategies in the structure-activity relationships of new cardiotonic agents 212
4-Dialkylamino-1-(5-substituted or unsubstituted 1-phenyl-1H-pyrazol-4-yl)butan-1-ols: synthesis and evaluation of analgesic, anti-inflammatory and platelet anti-aggregating activities 199
CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonists. 196
Affinity prediction on A1 adenosine receptor agonists: the chemometric approach 195
3-Acetyl-5-acylpyridin-2(1H)-ones and 3-acetyl-7,8-dihydro-2,5(1H,6H)-quinolinediones: synthesis, cardiotonic activity and computational studies 195
Exploring the QSAR of pyrazolo[3,4-b]pyridine, pyrazolo[3,4-b]pyridone and pyrazolo[3,4-b]pyrimidine derivatives as antagonists for A1 adenosine receptor. 188
Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptors 188
A chemometric approach to predict A1 agonist effect of adenosine analogues 177
2- substituted 5-acetyl-1,6-dihydro-6-oxo-3-pyridinecarboxylates: synthesis and cardiotonic activity 172
4-Substituted 1,5-diarylpyrazoles, analogues of celecoxib: synthesis and preliminary evaluation of biological properties 171
Structural basis for selective PDE 3 inhibition: a docking study 166
4-Substituted 1-methyl-1H-indazoles with analgesic, antiinflammatory and antipyretic activities 166
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line 166
CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists 160
A New Milrinone analog: Role of Binding to A1 Adenosine Receptor in its Positive Inotropic Effect on Isolated Guinea Pig and Rat Atria 159
Synthesis of 5-substituted 1-aryl-1H-pyrazole-4-acetonitriles, 4-methyl-1-phenyl-1H-pyrazole-3-carbonitrile and pharmacologically active 1-aryl-1H-pyrazole-4-acetic acids. 156
Synthesis and preliminary biological evaluation of novel N-substituted 1-amino-3-[1-methyl(phenyl)-1H-indazol-4-yloxy]-propan-2-ols interesting as potential antiarrhythmic, local anaesthetic and analgesic agents 155
New pyrazolo[3,4-d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation 154
Synthesis and Cardiotonic Activity of Novel Pyrimidine Derivatives. Crystallographic and Quantum Chemical Studies 154
An updated topographical model for phosphodiesterase 4 (PDE4) catalytic site 153
Synthesis, molecular modeling studies and pharmacological activity of selective A1 receptor antagonists 151
2-Pyridone derivatives as inotropic agents: synthesis, pharmacology and molecular modeling study 151
Unprecedented one-pot stereoselective synthesis of Knoevenagel-type derivatives via in situ condensation of N-methyleniminium salts of ethylenethiourea and ethyleneurea with active methylene reagents 144
Exploring the molecular basis of selectivity in A1 adenosine receptors antagonist: a case study 143
Structure-based Design, Parallel Synthesis, SAR and Molecular Modelling Studies of Thiocarbamates, New Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitor Isosteres of Phenethylthiazolylthiourea Derivatives. 142
Exploring the binding features of rimonabant analogues and acyclic CB1 antagonists: docking studies and QSAR analysis 142
New halogenated 4-aminopyrazolo[3,4-b]pyridines A1 adenosine receptor ligands 142
DNA-psoralens molecular recognition using molecular dynamics 139
Novel angular furo and thieno-quinolinones: synthesis and preliminary photobiological studies 138
Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model. 137
Synthesis of indole imminun salts as key-intermediates in a convergent multi-step one-pot stereoselective synthesis of new potent antiproliferative Knoevenagel-type agent 136
2-Pyridone derivatives as inotropic agents: synthesis, pharmacology and molecular modeling study 136
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation 136
Ionization Behaviour and Tautomerism-Dependent Lipophilicity of Pyridine-2(1H)-one Cardiotonic Agents 135
Synthesis and Pharmacological Characterization of Functionalized 2-Pyridones Structurally Related to the Cardiotonic Agent Milrinone 135
Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site 134
Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cells 132
Synthesis of 1-(2-chloro-2-phenylethyl)-6-methylthio-1-H-pyrazolo[3,4-d]pyrimidines 4-amino substituted and their biological evaluation 131
Insights into Structure-Activity Relationships from Lipophilicity Profiles of Pyridin-2(1H)-one Analogs of the Cardiotonic Agent Milrinone 130
Zups: the evolution of a new class of molecular descriptors 129
Synthesis and biological data of 4-amino-1-(2-chloro-2-phenylethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl esters, a new series of A1-adenosine receptor (A1AR) ligands 126
Development of a new topographical model for myocardial cGI-PDE catalytic site 124
Toward the identification of the cardiac cGMP inhibited-phosphodiesterase catalytic site 123
Quinolinedione nucleus as a novel scaffold for A1 and A2A adenosine receptor antagonists. 123
New pyrazolo[3,4-b]pyridones as selective A1 adenosine receptor antagonists: synthesis, biological evaluation and molecular modeling studies 122
New milrinone analogues:in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine and inhibition of cardiac type III phosphodiesterase 122
Towards the identification of the cardiac cAMP phosphodiesterase receptor site 119
Reaction of Sulfene with Heterocyclic N, N-Disubstituted alfa-Amino methyleneketones. IX. Synthesis of 1,2-Oxathiino [6,5-e] indole Derivatives. 119
Modulazioni Strutturali in O-[2-(N-Ftalimmido)etil] Acil(Aril)Tiocarbammati, Inibitori Non-Nucleosidici della Transcrittasi Inversa di HIV-1 118
Synthesis and biological evaluation of azole derivatives, analogues of bifonazole, with a phenylisoxazolyl or phenylpyrimidinyl moiety 117
null 117
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines 117
Exploring the binding features of rimonabant analogues and acyclic CB1 antagonists: docking studies and 3D-QSAR analysis 116
null 116
Synthesis of pyrazolo[3,4-d]pyridines selective antagonists of A1 adenosine receptors 115
Androstane derivatives: synthesis of substituted 6'-H-androst-2-eno*3,2-b*pyran-6'-ones. 112
Reaction of Sulfene with Heterocyclic N,N-Disubstituted alfa-Amino methyleneketones.XI. Synthesis of 1,2-Oxathiino[5,6-d]-1-benzoxepin Derivatives. 112
Molecular Modeling of DNA-psoralens complexes 110
QSAR study on new cardiotonic agents related to milrinone 109
In silico rationalization of the structural and physicochemical requirements for photobiological activity in angelicine derivatives and their heteroanalogues 109
Riconoscimento molecolare DNA-psoraleni mediante tecniche di dinamica molecolare 108
Synthesis, antimicrobial activity and molecular modelling studies of halogenated 4-[1H-imidazol-1-yl(phenyl)methyl]-1,5-diphenyl-1H-pyrazoles 105
Flavonoidverbindungen und Allantoin aus Anchusa officinalis L. 101
null 99
Synthesis, Biological Evaluation and Molecular Modeling Studies on Benzothiadiazine Derivatives as PDE4 Selective Inhibitors 97
New pyrazolo[3,4-b]pyridines antagonist of A1 adenosine receptors 95
null 95
omega-Dialkylaminoalkil Ethers of Phenyl-(5-substituted 1-phenyl-1H-pyrazol-4-yl)methanols with Analgesic and Anti-inflammatory Activity 94
Computational studies of the binding mode and 3D-QSAR analyses of symmetric formimidoester disulfides: a new class of non-nucleoside HIV-1 reverse transcriptase inhibitors 93
Glycoside und Depside aus den Blättern von Castanea sativa Mill. 92
Zupan's descriptors in QSAR applied to the study of a new class of cardiotonic agents 90
Inotropic Agents. Synthesis and Structure-Activity Relationships of New Milrinone Related cAMP PDEIII inhibitors 88
Studio computazionale di complessi di intercalazione al buio DNA-psoraleni Pavia, 27-29 maggio 1999 87
Synthesis and photobiological properties of 3-acylangelicins, 3-alkoxycarbonyl-angelicins and related derivatives 87
Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses 86
Synthesis of new pyrazolo[3,4-b]pyridines: new selective A1 adenosine receptor antagonists 79
Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses 43
Rational design, synthesis and biological evaluation of new 1,5-diarylpyrazole derivatives as CB1 receptor antagonists, structurally related to rimonabant 37
Synthesis of N-substituted-N-acylthioureas of 4-substituted piperazines endowed with local anaesthetic, antihyperlipidemic, antiproliferative activities and antiarrythmic, analgesic, antiaggregating actions 27
Totale 10.622
Categoria #
all - tutte 32.557
article - articoli 26.804
book - libri 0
conference - conferenze 5.753
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.114


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022949 43 85 70 91 26 43 63 254 39 85 45 105
2022/2023730 66 47 7 85 122 121 0 37 104 5 117 19
2023/2024361 20 59 11 51 38 51 20 15 9 12 35 40
2024/20251.322 24 91 40 105 189 130 99 248 72 62 131 131
2025/20262.381 285 58 167 194 363 231 428 111 134 223 96 91
2026/2027213 213 0 0 0 0 0 0 0 0 0 0 0
Totale 10.622